Metabolic effects of the birth control pill
- PMID: 7026112
- DOI: 10.1097/00003081-198109000-00018
Metabolic effects of the birth control pill
Abstract
PIP: The clinical and epidemiological literature is reviewed as to metabolic effects of oral contraceptives (OCs). Both the estrogens and the progestins in OCs cause biochemical alterations which have metabolic consequences. Changes in glucose, lipid, and protein metabolism suggest that the dosage of both estrogens and progestins should be minimized as much as possible. All studies with OCs show no changes in glucose tolerance, but all do consistently show elevated plasma insulin levels as a result of OC usage. This occurs because the pill causes a decrease in insulin sensitivity in healthy women. Increases in age and weight, regardless of OC usage, will also cause an increase in glucose tolerance. Oral glucose tolerance deteriorates in all OC user groups, the greatest deterioration being in the high-dose estrogen users. Women with a history of gestational diabetes or impaired glucose tolerance should be considered high-risk pill users. Lipid abnormalities as a result of pill usage are primarily due to estrogen content. Fasting triglyceride levels are increased in all estrogen users. High-risk factors to be considered in OC prescription are: moderate obesity; diabetes; history of gestational diabetes; hypertension; history of pancreatitis, gallbladder or liver disease; physical evidence of xanthomatosis; age over 30 and smoker; age over 35; family history of hyperlipidemia; and family history of early atherosclerotic vascular disease. Many of the pill-induced protein synthesis changes are similar to those which occur during pregnancy. These, too, are due to estrogen content.
Similar articles
-
The metabolic impact of oral contraceptives.Am J Obstet Gynecol. 1992 Oct;167(4 Pt 2):1177-84. doi: 10.1016/s0002-9378(12)90408-1. Am J Obstet Gynecol. 1992. PMID: 1415443 Review.
-
Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):732-4. doi: 10.1016/s0002-9378(16)32479-6. Am J Obstet Gynecol. 1982. PMID: 7039318
-
Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.Contraception. 1987 Mar;35(3):229-43. doi: 10.1016/0010-7824(87)90025-4. Contraception. 1987. PMID: 2956055
-
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.Contraception. 1995 Sep;52(3):143-9. doi: 10.1016/0010-7824(95)00153-2. Contraception. 1995. PMID: 7587185
-
Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.Am J Obstet Gynecol. 1988 Jun;158(6 Pt 2):1612-20. doi: 10.1016/0002-9378(88)90199-8. Am J Obstet Gynecol. 1988. PMID: 3287933 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources